Poteligeo 20 MG/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB25FYX19
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,246
Award facts
- Contract value 100% obligated
- $41,246.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $41,246.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Poteligeo 20 mg/5 ml vials. This delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The award was not subject to any set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical procurement market based on its capabilities and pricing.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, primarily distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's portfolio of federal contracts demonstrates significant experience delivering specialized pharmaceutical products, including oncology treatments, vaccines, and other advanced therapeutics to military health systems. Poteligeo, an anti-cancer immunotherapy medication, aligns with the company's established track record of supplying high-value specialty pharmaceuticals to support the medical needs of military personnel and their families across DoD healthcare networks.
Quick answers
Who was awarded contract SPE2DB25FYX19?
SPE2DB25FYX19 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FYX19 worth?
The government has obligated $41,246 on SPE2DB25FYX19.
Is contract SPE2DB25FYX19 an order under another contract?
Yes. SPE2DB25FYX19 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX19 competed?
The extent of competition for SPE2DB25FYX19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award